Your browser doesn't support javascript.
loading
Phase I trial of gemcitabine combined with capecitabine and erlotinib in advanced pancreatic cancer: a clinical and pharmacological study.
Francois, E; Bennouna, J; Chamorey, E; Etienne-Grimaldi, M C; Renée, N; Senellart, H; Michel, C; Follana, P; Mari, V; Douillard, J Y; Milano, G.
Affiliation
  • Francois E; Department of Medical Oncology, Antoine Lacassagne Cancer Research Center, Nice, France. eric.francois@nice.unicancer.fr
Chemotherapy ; 58(5): 371-80, 2012.
Article in En | MEDLINE | ID: mdl-23235319

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Quinazolines / Antineoplastic Combined Chemotherapy Protocols / Deoxycytidine / Fluorouracil Type of study: Etiology_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Chemotherapy Year: 2012 Type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Quinazolines / Antineoplastic Combined Chemotherapy Protocols / Deoxycytidine / Fluorouracil Type of study: Etiology_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Chemotherapy Year: 2012 Type: Article Affiliation country: France